Items where Author is "Xin Hui, Khoo"
Up a level |
Article
Xin Hui, Khoo and Nik Muhamad Affendi, Nik Arsyad and Leow, Alex Hwong Ruey and Hilmi, Ida Normiha (2023) Long term efficacy and persistence of biologics therapy in Crohn’s disease in multiracial Asian country. Journal of Gastroenterology and Hepatology, 38 (S3). p. 271. ISSN 0815-9319 E-ISSN 1440-1746
hilmi, ida normiha and Nik Muhamad Affendi, Nik Arsyad and Shahrani, Shahreedhan and Mohamed Talha, Abdul Malik and Leow, alex hwong-ruey and Xin Hui, Khoo (2023) High accuracy of a simplified, practical algorithm in a differentiating Crohn’s disease from Intestinal Tuberculosis. Digestive disease, 41 (4). pp. 581-588. ISSN 0257-2753 E-ISSN 1421-9875
Nik Muhamad Affendi, Nik Arsyad and Xin Hui, Khoo and Chuah, Kee Huat and Hilmi, Ida (2021) Biologic exposure of short duration results in a marked reduction in cumulative surgical rates in Malaysian patients with inflammatory bowel disease. Journal of Gastroenterology and Hepatology, Vol 36 S2. p. 233. ISSN 1440-1746
Proceeding Paper
Nik Muhamad Affendi, Nik Arsyad and Xin Hui, Khoo and leow, alex hwong ruey and hilmi, ida normiha (2023) Long term efficacy and persistence of Biologics Therapy in Crohn Disease in Multiracial Asian Country: A real world experience. In: GUT 2023, Kuala Lumpur.
Nik Muhamad Affendi, Nik Arsyad and Xin Hui, Khoo and Chuah, Kee Huat and Hilmi, ida normiha (2022) Biologic exposure of short duration results in a marked reduction in cumulative surgical rates in Malaysian patients with inflammatory bowel disease. In: GUT 2022, kuala Lumpur convention centre. (Unpublished)
Nik Muhamad Affendi, Nik Arsyad and Xin Hui, Khoo and hilmi, ida normiha (2022) Efficacy, safety and persistence of Ustekinumab versus Infliximab in bionaive patients with moderate to severe Crohn disease patients: a real world experience. In: GUT 2022, 19 - 21 August 2022, Kuala Lumpur Convention Centre. (Unpublished)
Fairul, Mohd and Nik Muhamad Affendi, Nik Arsyad and Shahrani, Shahreedhan and Xin Hui, Khoo and hilmi, ida normiha (2022) Impact of early versus late use of biologic therapy on cumulative surgical rates in patients with IBD. In: GUT 2022, 19 - 21 August 2022, Kuala Lumpur Convention Centre. (Unpublished)